WuXi AppTec executes share repurchase plan on SSE

WuXi AppTec, a leading pharmaceutical and biotechnology company, announced further details regarding its ongoing share repurchase program. On June 10, 2025, the company repurchased 459,493 A-shares on the Shanghai Stock Exchange at prices between RMB 64.65 and RMB 66.28 per share, for a total consideration of RMB 29,995,106.1. This repurchase, part of a larger plan authorized by the board, aims to enhance shareholder value. The repurchased shares will be held as treasury stock and used for future company initiatives. Since April 18, 2025, WuXi AppTec has repurchased a total of 6,888,343 A-shares.